E. Englund

发表

FDA Approval Summary: TAS-102

K. He, P. Keegan, R. Pazdur, 2017, Clinical Cancer Research.

The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor Agonists.

Noel Southall, C. Austin, Wei Zheng, 2011, MedChemComm.

Novel Antibacterial Class

Xiaoan Ruan, N. Soni, Philip J. Merta, 2003, Antimicrobial Agents and Chemotherapy.

Synthesis and antibacterial activity of 6-O-arylbutynyl ketolides with improved activity against some key erythromycin-resistant pathogens.

G. Stone, Melissa M. Daly, E. Englund, 2003, Journal of medicinal chemistry.

Synthesis and evaluation of quinazolin-4-ones as hypoxia-inducible factor-1α inhibitors.

Ruili Huang, C. Austin, M. Xia, 2011, Bioorganic & medicinal chemistry letters.

Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors.

Ruili Huang, C. Austin, Jun R Huh, 2013, ACS medicinal chemistry letters.

Synthesis and structure of preorganized, C(3)-symmetric trilactam scaffolds with convergently oriented (S)-acetylthiomethyl appendages.

E. Englund, S. D. Burke, J. E. Campbell, 2002, Organic letters.

Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study

L. Leach, P. Langhorne, C. Caltagirone, 2018, Alzheimer's & Dementia.

Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system.

P. Wipf, G. Powis, S. Lynch, 2005, Organic & biomolecular chemistry.

Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-α.

R. Clarke, E. Rosen, Y. Tomita, 2014, Molecular endocrinology.

Table 7, Summary of data in PubChem

Steve Titus, Wenwei Huang, Juan J. Marugan, 2010 .